Patent · US Active

IL-6 receptor•IL-6 direct fusion protein

US7531644B2 · kind B2 · utility

2Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2006
Grant dateMay 12, 2009
Priority date
Expiry dateOct 10, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/125
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention intends to provide an IL-6R•IL-6 fusion protein and the like in which IL-6R and IL-6 are directly linked without a linker.The IL-6 receptor•IL-6 fusion protein of the present invention has a structure in which one amino acid residue constituting IL-6 receptor and one amino acid residue constituting IL-6 are directly bonded.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.